Nong Andy, Taylor Michael D, Clewell Harvey J, Dorman David C, Andersen Melvin E
The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina 27709, USA.
Toxicol Sci. 2009 Mar;108(1):22-34. doi: 10.1093/toxsci/kfn264. Epub 2008 Dec 19.
Manganese (Mn) is an essential nutrient required for normal tissue growth and function. Following exposures to high concentrations of inhaled Mn, there is preferential accumulation of Mn in certain brain regions such as the striatum and globus pallidus. The goal of this research was to complete a physiologically based pharmacokinetic (PBPK) model for Mn in rats and scale the model to describe Mn tissue accumulation in nonhuman primates exposed to Mn by inhalation and diet. The model structure includes saturable tissue binding with association and dissociation rate constants, asymmetric tissue permeation flux rate constants to specific tissues, and inducible biliary excretion. The rat PBPK model described tissue time-course studies for various dietary Mn intakes and accounted for inhalation studies of both 14-day and 90-day duration. In monkeys, model parameters were first calibrated using steady-state tissue Mn concentrations from rhesus monkeys fed a diet containing 133 ppm Mn. The model was then applied to simulate 65 exposure days of weekly (6 h/day; 5 days/week) inhalation exposures to soluble MnSO(4) at 0.03 to 1.5 mg Mn/m(3). Sensitivity analysis showed that Mn tissue concentrations in the models have dose-dependencies in (1) biliary excretion of free Mn from liver, (2) saturable tissue binding in all tissues, and (3) differential influx/efflux rates for tissues that preferentially accumulate Mn. This multispecies PBPK model is consistent with the available experimental kinetic data, indicating preferential increases in some brain regions with exposures above 0.2 mg/m(3) and fairly rapid return to steady-state levels (within several weeks rather than months) after cessation of exposure. PBPK models that account for preferential Mn tissue accumulation from both oral and inhalation exposures will be essential to support tissue dosimetry-based human risk assessments for Mn.
锰(Mn)是正常组织生长和功能所需的必需营养素。在吸入高浓度的锰后,锰会优先在某些脑区如纹状体和苍白球中积累。本研究的目的是建立大鼠锰的生理药代动力学(PBPK)模型,并对该模型进行缩放,以描述通过吸入和饮食接触锰的非人灵长类动物体内锰的组织积累情况。模型结构包括具有结合和解离速率常数的饱和组织结合、向特定组织的不对称组织渗透通量速率常数以及诱导性胆汁排泄。大鼠PBPK模型描述了不同饮食锰摄入量下的组织时程研究,并考虑了为期14天和90天的吸入研究。在猴子中,首先使用喂食含133 ppm锰饮食的恒河猴的稳态组织锰浓度对模型参数进行校准。然后应用该模型模拟每周(每天6小时;每周5天)吸入0.03至1.5 mg Mn/m³可溶性硫酸锰(MnSO₄)65天的暴露情况。敏感性分析表明,模型中的锰组织浓度在以下方面具有剂量依赖性:(1)肝脏中游离锰的胆汁排泄;(2)所有组织中的饱和组织结合;(3)优先积累锰的组织的差异流入/流出速率。这种多物种PBPK模型与现有的实验动力学数据一致,表明暴露于0.2 mg/m³以上时某些脑区会优先增加,并且在停止暴露后相当迅速地恢复到稳态水平(在几周内而不是几个月内)。考虑到口服和吸入暴露中锰的优先组织积累的PBPK模型对于支持基于组织剂量学的锰的人体风险评估至关重要。